Letko Brosseau & Associates Inc. Has $3.24 Million Stock Position in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Letko Brosseau & Associates Inc. cut its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 6.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 40,000 shares of the exchange traded fund’s stock after selling 2,950 shares during the period. Letko Brosseau & Associates Inc.’s holdings in SPDR S&P Biotech ETF were worth $3,244,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Provident Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 3,000.0% in the 1st quarter. Provident Wealth Management LLC now owns 310 shares of the exchange traded fund’s stock valued at $25,000 after buying an additional 300 shares in the last quarter. Garrison Bradford & Associates Inc. bought a new stake in SPDR S&P Biotech ETF in the 1st quarter valued at about $39,000. Compass Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 46.0% in the 1st quarter. Compass Wealth Management LLC now owns 635 shares of the exchange traded fund’s stock valued at $51,000 after buying an additional 200 shares in the last quarter. Golden State Wealth Management LLC increased its position in SPDR S&P Biotech ETF by 100.0% in the 1st quarter. Golden State Wealth Management LLC now owns 638 shares of the exchange traded fund’s stock valued at $52,000 after buying an additional 319 shares in the last quarter. Finally, O Shaughnessy Asset Management LLC increased its position in SPDR S&P Biotech ETF by 38.6% in the 4th quarter. O Shaughnessy Asset Management LLC now owns 718 shares of the exchange traded fund’s stock valued at $65,000 after buying an additional 200 shares in the last quarter.

SPDR S&P Biotech ETF Price Performance

Shares of SPDR S&P Biotech ETF stock opened at $85.84 on Wednesday. SPDR S&P Biotech ETF has a one year low of $66.66 and a one year high of $105.47. The firm has a market capitalization of $4.65 billion, a price-to-earnings ratio of 11.47 and a beta of 0.97. The business has a 50-day simple moving average of $83.92 and a 200 day simple moving average of $84.27.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.